Edward T. Mathers - Jun 2, 2022 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MIRM	Stock Option (right to buy)	Award	$0	+17K		$0.00	17K	Jun 2, 2022	Common Stock	17K	$23.51	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2023 annual stockholder meeting.